CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Preventing Youth Suicide National Collaborative
CHA Responds to 340B Draft Bill and Request for Information
2024 Policy Priorities for the 118th Congress
Preventing Youth Suicide National Collaborative
The collaborative is part of Children Hospital Association's ongoing work to address the youth mental health crisis.
April 23, 2024
CHA Responds to 340B Draft Bill and Request for Information
The 340B program supports children’s hospitals in their mission to serve low-income and underinsured children regardless of their insurance status.
April 04, 2024
2024 Policy Priorities for the 118th Congress
Children’s Hospital Association (CHA) advances child health through innovation in the quality, cost, and delivery of care in children’s hospitals and health systems.
April 04, 2024
